Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N V COM | 4,639,304 | 4,639,304 | 0 | $115.75M | $128.74M | 59.53% | +$12.99M |
| Alumis Inc | 4,619,803 | 4,619,803 | 0 | $18.43M | $45.09M | 20.85% | +$26.66M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 489,194 | 489,194 | 0 | $13.48M | $18.31M | 8.46% | +$4.82M |
| ALX Oncology Holdings Inc.(ALXO) | 9,699,925 | 9,699,925 | 0 | $17.75M | $10.96M | 5.07% | -$6.79M |
| Lyell Immunopharma, Inc.(LYEL) | 473,479 | 337,697 | -135,782 | $7.69M | $10.39M | 4.81% | +$2.71M |
| Artiva Biotherapeutics, Inc.(ARTV) | 1,148,975 | 648,507 | -500,468 | $3.30M | $2.78M | 1.29% | -$515.5K |